Subject Index

Adherence, granulocytes . 111 Age-involuted human thymus, terminal

transferase (TdT) . 45 Allogeneic effect, TNP-modified lym-

phoid cells. 368 Allograft rejection, lizard, ....... , 484 Alternative pathway of complement sys-

tem, Ehrlich ascites cells .... , . .. 397 Alveolar macrophage!), a.<;pergillus fumi-

gatus spores.. .., ....... ,. 53 Antibody-forming cells, morphology 296 Antibody-forming cells, secretory activi-

ty . 296 Antibody synthesis, autorosette forming

cells. . . ..... . Antigenic determinants, Thy 1 and hu-

man IgG. . 428 Anti-influenza virus activity, macropha-

ges. . . 458 Arachidonic acid release, complement

components. 473 Aspergillus fumigaws spores, alveolar

macrophages _ 53 Autorosette forming cells, suppressive

activity ... _ ...

Bioreactors, production of lymphokines . 12

Carrageenan-induced suppression of T­lymphocyte, indomethacin and ETY A 275

CI to C3, macrophage culture superna-tant . . . ....... , ,. 177

Coelomic fluid, mitogenic effect 157 Colony-stimulating factors, macrophage

anti-toxoplasma activity . . . . . .. 146 Colorectal tumors, interferon production 494 Complement components, macrophage

culture supernatant. . . . . 177 Complement components, release of ara-

chidonic acid ....... 473 Complement, late components. . . 473 CTL precursor, serum factor. 212 Cytolytic, cytostatic, and cytotoxic acti-

vities, macrophages. . . . . . . . .. 251 Cytotoxic T cell response, graft-versus-

host reactions. . . . 308 Cytotoxic T lymphocytes, in vivo diffe-

rentiation 212

Diabetics, fourth component of comple-ment (C4) . . . . . .. 335

EACI42 and EAC1423 177 Earthworm (Lumbricus terrestris), mito-

genic effect ..... " .. 157 Ecto-5' -nucleotidase, monoclonal anti-

body. . . . . . . . . . .. 20} Ehrlich ascites cells, human complement

system. . . . . . . . 397 ELISA, ferritin labeled antibodies 439 En7.yme-linked immunosorbent assay,

pigeon breeders' disease .. 168 Enzyme-linked immunosorbent assay

(ELISA). repeated use ... 24 ETY A, carrageenan-induced suppression 275

Ferritin-labeled antibodies, ELISA. 439 Fibroblasts, synovial . . . .. .. 360 Fourth component of complement (C4),

gene and haplotype frequencies ... 335

Gene and haplotype frequencies, fourth component of complement (C4) . 335

Graft-versus-host reaction, cytotoxic T cell response. . . ,. . . . . . . 308

Graft-versus-host reaction, lizard. 484 Granulocytes, adherence and migration 111 Granulocyte-macrophage colony stimu-

lating factor. . . , .. , 12

Hapten-binding B Cells, activation. 345 Hepatitis virus infection, induction of

natural killer cells. 35 Hodgkin derived ce111ines, interleukin-l-

like activity .... , . . 318 Human autologous mixed lymphocyte

reaction, analysis _ . . . . . .. 190 Human complement system, alternative

pathway. 397 Human peripheral blood mononuclear

cells, isolation. . . 238 Human thymus, age-involuted. 45

IL-2 receptor induction, antigen-present-ing cells . . . . . . .. 96

Indomethacin, carrageenan-induced sup-pression. 275

Interferon-y . . 12 Interferon gamma production, lack of

correlation with Lyt 1,2 phenotype. . 219 Interferon gamma production, murine

spleen cells and T cell lines . 219 Interferon, hepatitis virus infection. . .. 35

Interferon (IFN-y), macrophage anti­toxoplasma activity, , .

Interferon production, colorectal tumors Interleukin- l-like activity. Hodgkin de­

rived ceUlines, , , ..... Interleukin 2 . . Involution of lymphoid tissues. stress re-

lated, , , . , ....... . Ionophore-induced changes, macropha-

ges ..

LIF production. suppressor T cells. Lizard, graft-versus-host reaction . Lizard, mixed leukocyte reaction .. Lymphocyte, macrophage cytotoxicity-

inducing. . . ..... . Lymphoid tissues, involution ...... . Lymphokines. production in bioreactors L YT - I cells, perpetual proliferation

Macrophage activation. bacterial lipopo-lysaccharide. . . ..... ,

Macrophage activation, secretion of plas­minogen activator.

Macrophage anti-toxoplasma activity, immune interferon (lFN-y) ,

Macrophage antitumor activity, cytoly­tic, cytostatic, and cytotoxic activities.

Macrophage culture supernatant, com-plement components ....... .

Macrophage cytotoxicity factor ... . Macrophage cytotoxicity, lymphocyte

induced Macrophage factor, anti-tumour effect. Macrophage migration inhibitory factor. Macrophages. anti-influenza virus activi-

ty . . . ........ , Macrophages, ionophore-induced func­

tional changes. . . . . . Major histocompatibility complex, hap­

ten-binding B cells .... MHC-restriction, graft-versus-host reac­

tions. Migration, granulocytes ....... . Mitogenic effect, earthworm (Lumbricus

terrestris) ......... . Mixed leukocyte reaction, lizard ..... Mixed lymphocyte reactions, suppressor

T cells. Monoclonal antibody analysis, human

autologous mixed lymphocyte reaction Monocytes, cytolytic activities .. Mouse hepatitis virus, prutection . Mouse hepatitis virus infection, suscepti­

ble mouse strains . . . . . .

Natural antibodies. various tumor cells ..

146 494

318 12

286

446

263 484 484

84 286

12 96

410

410

146

251

177 12

84 118

12

458

446

345

308 111

157 484

263

190 251

62

35

131

Subject Index' 507

Natural killer cells, hepatitis virus infec­tion .

Nu/Nu mice, T -helper activity.

Percoll, isolation of human peripheral blood mononuelear cells ...... .

Peripheral blood lymphocytes, interferon production ..... .

Pigeon breeders' disease, enzyme linked immune sorbent assay ........ .

Plasma cells, erythrocyte lysing IgG anti-body. . .....

Plasma cells, precursors . Plasm.inogen activator. macrophage acti-

vation ........ . Prostaglandin-mediated system, T-cell

recruitment .. Proteins, fibroblasts.

Repetitive signals, L YT -1 cells ..... . Rever~e haemolytic plaque assays, com-

panson

Serum factor, CTL precursor. Silica, protection against infection with

mouse hepatitis virus .. Splccn cells, interferon gamma produc·

tion ... Suhfractionation, Percoll . . . . . . . Suppressive accivity, autorosette forming

cells . . . .. . ..... . Suppressor T cells, l.IP production .. . Synovial fibroblasts, antigenicity .. . Systemic anti-tumour effect, macrophage

fac tor . . . ... ... ... _

T-cell lines, interferon gamma produc-tion . . . . ... ..

T-cell recruitment, prostaglandin-media­ted.

T-he1per activity, NulNu and normal BALB/c mice .....

T -lymphocyte proliferation, carrageenan-induced suppression ........ .

T-Iymphocytes. anti-tumour effect ... . Terminal transferase (fdT). human thy-

mus . . .. . ..... Thy I, antigenic determinants shared by

human IgG .............. . TNP-modified lymphoid cells, allogeneic

effect , ...... . Tumor cells, natural antibodies. Tumor lysis, macrophage activation

Urethane carcinogenesis, natural ancibo­dies ...

35 228

238

494

168

72 72

410

382 360

96

403

212

62

219 238

1 263 360

118

219

382

228

275 118

45

428

368 131 410

131